|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Fixed maturity, bonds held-to-maturity, at amortized cost (Fair value $8,968,690 and $8,130,084) | ||||||||||||||||||||
| Fixed maturity, bonds held-to-maturity, at amortized cost, net of allowance for credit losses of $21,385 in 2020 (Fair value $8,501,656 in 2020 and $8,968,690 in 2019) | ||||||||||||||||||||
| Fixed maturity, bonds available-for-sale, at fair value (Amortized cost $6,447,577 in 2020 and $6,435,670 in 2019) | ||||||||||||||||||||
| Equity securities, at fair value (Cost $696,474 and $757,583) | ||||||||||||||||||||
| Equity securities, at fair value (Cost $693,708 in 2020 and $663,058 in 2019) | ||||||||||||||||||||
| Mortgage loans on real estate, net of allowance | ||||||||||||||||||||
| Mortgage loans on real estate, net of allowance for credit losses of $59,445 in 2020 | ||||||||||||||||||||
| Policy loans | ||||||||||||||||||||
| Investment real estate, net of accumulated depreciation of $260,893 in 2020 and $256,757 in 2019 | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Other invested assets | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investments in unconsolidated affiliates | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Reinsurance recoverables | ||||||||||||||||||||
| Reinsurance recoverables, net of allowance for credit losses of $17,713 in 2020 | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Premiums due and other receivables | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $263,857 in 2020 and $257,907 in 2019 | ||||||||||||||||||||
| Current tax receivable | ||||||||||||||||||||
| Prepaid pension | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Separate account assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Life | ||||||||||||||||||||
| Annuity | ||||||||||||||||||||
| Health | ||||||||||||||||||||
| Policyholders’ account balances | ||||||||||||||||||||
| Policy and contract claims | ||||||||||||||||||||
| Unearned premium reserve | ||||||||||||||||||||
| Other policyholder funds | ||||||||||||||||||||
| Liability for retirement benefits | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||||
| Current tax payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Separate account liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| American National stockholders’ equity: | ||||||||||||||||||||
| Common stock, $1.00 par value, Authorized 50,000,000 in 2020 and 2019, Issued 30,832,449 in 2020 and 2019 Outstanding 26,887,200 shares in 2020 and 2019 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Total American National stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
